Publikationen in Zusammenarbeit mit Forschern von Dalhousie University (9)

2010

  1. Trans- but not cis-resveratrol impairs angiotensin-II-mediated vascular inflammation through inhibition of NF-κB activation and peroxisome proliferator-activated receptor-γ upregulation

    Journal of Immunology, Vol. 185, Núm. 6, pp. 3718-3727

2009

  1. Menopause and ovariectomy cause a low grade of systemic inflammation that may be prevented by chronic treatment with low doses of estrogen or losartan

    Journal of Immunology, Vol. 183, Núm. 2, pp. 1393-1402

2007

  1. Roflumilast inhibits leukocyte-endothelial cell interactions, expression of adhesion molecules and microvascular permeability

    British Journal of Pharmacology, Vol. 152, Núm. 4, pp. 481-492

2006

  1. Angiotensin II-induced mononuclear leukocyte interactions with arteriolar and venular endothelium are mediated by the release of different CC chemokines

    Journal of Immunology, Vol. 176, Núm. 9, pp. 5577-5586

  2. Olive oil-based lipid emulsion's neutral effects on neutrophil functions and leukocyte-endothelial cell interactions

    Journal of Parenteral and Enteral Nutrition, Vol. 30, Núm. 4, pp. 286-296

2005

  1. Effect of boldine, secoboldine, and boldine methine on angiotensin II-induced neurtrophil recruitment in vivo

    Journal of Leukocyte Biology, Vol. 78, Núm. 3, pp. 696-704

  2. Erythromycin exerts in vivo anti-inflammatory activity downregulating cell adhesion molecule expression

    British Journal of Pharmacology, Vol. 144, Núm. 2, pp. 190-201

2003

  1. Effect of two phenanthrene alkaloids on angiotensin II-induced leukocyte-endothelial cell interactions in vivo

    British Journal of Pharmacology, Vol. 140, Núm. 6, pp. 1057-1067

2002

  1. Rolipram inhibits leukocyte-endothelial cell interactions in vivo through P- and E-selectin downregulation

    British Journal of Pharmacology, Vol. 135, Núm. 8, pp. 1872-1881